EA200000112A1 - Новая композиция - Google Patents

Новая композиция

Info

Publication number
EA200000112A1
EA200000112A1 EA200000112A EA200000112A EA200000112A1 EA 200000112 A1 EA200000112 A1 EA 200000112A1 EA 200000112 A EA200000112 A EA 200000112A EA 200000112 A EA200000112 A EA 200000112A EA 200000112 A1 EA200000112 A1 EA 200000112A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new composition
ssri
blocker
published
pharmaceutical composition
Prior art date
Application number
EA200000112A
Other languages
English (en)
Russian (ru)
Inventor
Пол Джон Каммингс
Ян Фредерик Таллоч
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000112A1 publication Critical patent/EA200000112A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EA200000112A 1997-07-11 1998-07-07 Новая композиция EA200000112A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition
PCT/EP1998/004971 WO1999002142A2 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker

Publications (1)

Publication Number Publication Date
EA200000112A1 true EA200000112A1 (ru) 2000-10-30

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000112A EA200000112A1 (ru) 1997-07-11 1998-07-07 Новая композиция

Country Status (26)

Country Link
EP (1) EP0996466A2 (xx)
JP (1) JP2002508003A (xx)
KR (1) KR20010021644A (xx)
CN (1) CN1262627A (xx)
AP (1) AP2000001728A0 (xx)
AR (1) AR016128A1 (xx)
AU (1) AU9340198A (xx)
BG (1) BG104119A (xx)
BR (1) BR9810996A (xx)
CA (1) CA2295822A1 (xx)
CO (1) CO4950552A1 (xx)
DZ (1) DZ2556A1 (xx)
EA (1) EA200000112A1 (xx)
GB (1) GB9714675D0 (xx)
HU (1) HUP0003074A3 (xx)
ID (1) ID24191A (xx)
IL (1) IL133869A0 (xx)
MA (1) MA24604A1 (xx)
NO (1) NO20000107L (xx)
OA (1) OA11276A (xx)
PE (1) PE99699A1 (xx)
PL (1) PL338017A1 (xx)
SK (1) SK72000A3 (xx)
TR (1) TR200000074T2 (xx)
WO (1) WO1999002142A2 (xx)
ZA (1) ZA986138B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE457169T1 (de) 1998-10-15 2010-02-15 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
EP1793818A2 (en) * 2004-09-17 2007-06-13 Neurocure Ltd. Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
CN100469356C (zh) * 2006-09-08 2009-03-18 山东益康药业有限公司 复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
AU6776196A (en) * 1995-08-16 1997-03-12 Eli Lilly And Company Potentiation of serotonin response
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
NO20000107D0 (no) 2000-01-10
BR9810996A (pt) 2000-08-08
DZ2556A1 (fr) 2003-02-15
PL338017A1 (en) 2000-09-25
CO4950552A1 (es) 2000-09-01
ID24191A (id) 2000-07-13
AP2000001728A0 (en) 2000-03-31
HUP0003074A3 (en) 2001-12-28
JP2002508003A (ja) 2002-03-12
CN1262627A (zh) 2000-08-09
SK72000A3 (en) 2000-12-11
GB9714675D0 (en) 1997-09-17
AR016128A1 (es) 2001-06-20
WO1999002142A2 (en) 1999-01-21
TR200000074T2 (tr) 2000-05-22
BG104119A (en) 2000-12-29
WO1999002142A3 (en) 1999-04-15
PE99699A1 (es) 1999-12-21
CA2295822A1 (en) 1999-01-21
MA24604A1 (fr) 1999-04-01
EP0996466A2 (en) 2000-05-03
OA11276A (en) 2003-07-31
IL133869A0 (en) 2001-04-30
HUP0003074A2 (hu) 2001-01-29
AU9340198A (en) 1999-02-08
KR20010021644A (ko) 2001-03-15
NO20000107L (no) 2000-01-10
ZA986138B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
ES2195970T3 (es) L-ribavirina y usos de la misma.
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
BR9808491A (pt) Compostos calcilìticos
SE9704546D0 (sv) Novel compounds
EA200001039A1 (ru) Кальцилитические соединения
AR016981A2 (es) Polipeptidos sinteticos
SE9802937D0 (sv) Novel compounds
ES2181168T3 (es) Mezclas solidas a base de sulfonilureas y adyuvantes.
EA200000112A1 (ru) Новая композиция
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
ES2170396T3 (es) Composiciones farmaceuticas a base de diclofenac.
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
EA199800753A1 (ru) Бензотиофены, составы их содержащие и способы с их использованием
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
ES2174150T3 (es) Procedimiento para la obtencion de 4-hidroxianilinas.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
NO985079L (no) Eksplosiv formulering
ES2158441T3 (es) Arilheterociclos con actividad herbicida.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
ES2116946B1 (es) Composicion para la obtencion de un aguardiente.